Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI034070-03
Application #
2069158
Study Section
Experimental Virology Study Section (EVR)
Project Start
1993-12-01
Project End
1998-11-30
Budget Start
1995-12-01
Budget End
1996-11-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Pennsylvania State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
129348186
City
Hershey
State
PA
Country
United States
Zip Code
17033
Brehm, M; Samaniego, L A; Bonneau, R H et al. (1999) Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0. Virology 256:258-69
Boesteanu, A; Brehm, M; Mylin, L M et al. (1998) A molecular basis for how a single TCR interfaces multiple ligands. J Immunol 161:4719-27
Blaney Jr, J E; Nobusawa, E; Brehm, M A et al. (1998) Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity. J Virol 72:9567-74
Brehm, M A; Bonneau, R H; Knipe, D M et al. (1997) Immunization with a replication-deficient mutant of herpes simplex virus type 1 (HSV-1) induces a CD8+ cytotoxic T-lymphocyte response and confers a level of protection comparable to that of wild-type HSV-1. J Virol 71:3534-44
Bonneau, R H; Brehm, M A; Kern, A M (1997) The impact of psychological stress on the efficacy of anti-viral adoptive immunotherapy in an immunocompromised host. J Neuroimmunol 78:19-33
Fu, T M; Bonneau, R H; Epler, M et al. (1996) Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Virology 222:269-74
Salvucci, L A; Bonneau, R H; Tevethia, S S (1995) Polymorphism within the herpes simplex virus (HSV) ribonucleotide reductase large subunit (ICP6) confers type specificity for recognition by HSV type 1-specific cytotoxic T lymphocytes. J Virol 69:1122-31